We interviewed Mudarshiru Bbuye, coordinator of the Coalition’s Virology, Immunology and Diagnostics working group, about his work in the area of infectious diseases and his collaboration with the Coalition. Bbuye is a research fellow at the Makerere University Lung Institute.

We interviewed Prof. Caesar Atuire, a member of the Coalition’s Ethics Working Group, about “Country ownership in global health”, an opinion piece by Dr Abdisalan Mohamed Noor published earlier this year in PLOS Global Public Health. Prof. Atuire shared his perspective on Dr Noor’s lessons learned and their importance for a fairer, more global response to future pandemics.

We interviewed Prof. Caesar Atuire, a member of the Coalition’s Ethics Working Group, about “Country ownership in global health”, an opinion piece by Dr Abdisalan Mohamed Noor published earlier this year in PLOS Global Public Health. Prof. Atuire shared his perspective on Dr Noor’s lessons learned and their importance for a fairer, more global response to future pandemics.

Nearly two years into the COVID-19 pandemic, Dr Wilber Sabiiti, co-chair of the coalition's Virology, Immunology and Diagnostics Working Group, makes a case for the need to strengthen context-specific evidence generation to guide pandemic strategies. In this Viewpoint, he looks at diverging approaches in Uganda and Tanzania, in their use of national lockdowns.

The coalition's Social Science Working Group and co-signatories have published a viewpoint on vaccine equity, arguing that a temporary TRIPS waiver is needed for COVID-19 vaccines and other medicines. Vaccine inequity is amongst the most significant social justice issues of our generation, and it poses a major threat to the global COVID-19 response. Urgent action is needed to improve equity and bring an end to the COVID-19 pandemic, including in low- and middle-income countries.